EUVIMEDEUVIMED entdecken
Systematische ÜbersichtMetaanalyseOpen Access · CC BY 4.0

Role of Vitamin D Supplementation in Chronic Liver Disease: A Systematic Review and Meta-Analysis of Randomized Controlled Trials

Petrana Martinekova iD, Mahmoud Obeidat, Mihaela Topala, Szilárd Váncsa, Dániel Sándor Veres, Ádám Zolcsák, Miheller Pál, László Földvári-Nagy, Peter Banovcin, Bálint Erőss, Péter Hegyi, Krisztina Hagymasi

Nutrition Reviews · 01.11.2025 · 83 (11) · 2043-2054

DOI: 10.1093/nutrit/nuaf117 ↗

Kurz gefasst

Systematische Übersicht in der Zeitschrift Nutrition Reviews, online erschienen am 11.07.2025. Verfasst von Petrana Martinekova und 11 weiteren Autor:innen. Beteiligte Einrichtung: Centre for Translational Medicine, Semmelweis University, Budapest 1085, Hungary. Hauptthemen laut MEDLINE: Vitamin D, Dietary Supplements, Vitamin D Deficiency, Liver Diseases. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 102 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Context

Vitamin D deficiency is highly prevalent in chronic liver disease. Although international societies recommend vitamin D supplementation in cases of proven deficiency, the impact of vitamin D on chronic liver disease remains uncertain.

Objective

Our aim was to evaluate the effects of vitamin D supplementation in patients with chronic liver disease by conducting a systematic review and meta-analysis of randomized controlled trials (RCTs). Data Sources We systematically searched PubMed, EMBASE and the Cochrane Library on July 2, 2024. Data Extraction Our primary outcomes involved survival, controlled attenuation parameter (CAP), liver stiffness measurement (LSM), and effects on changes in liver enzymes. Secondary outcomes included lipid profile and homeostasis model assessment of insulin resistance (HOMA-IR), among others. The pooled risk ratio (RR), mean difference (MD), and corresponding 95% CIs were calculated using the random-effects model. Data Analysis Forty-six RCTs were included, comprising 4084 patients. When we compared the vitamin D group with the control, the RR for overall survival was 1.14 (95% CI, 0.85-1.54; 4 RCTs) at 6 months and 0.99 (95% CI, 0.83-1.17; 4 RCTs) at the 12-month follow-up. Vitamin D supplementation did not result in a lower CAP (MD, −23.50 dB/m; 95% CI, −81.72 to 34.72; 3 RCTs) and LSM (MD, −0.65 kPa; 95% CI, −1.98 to 0.68; 3 RCTs). A significant reduction in HOMA-IR was observed in the vitamin D group (MD, −0.31; 95% CI, −0.62 to −0.01; 15 RCTs). Alanine aminotransferase (ALT) (MD, −4.98 IU/L; 95% CI, −8.28 to −1.68; 24 RCTs), aspartate aminotransferase (AST) (MD, −3.33 IU/L; 95% CI, −6.25 to −0.40; 23 RCTs), gamma-glutamyl transferase (GGT) (MD, −5.14 IU/L; −6.40; −3.88; 11 RCTs), triglycerides (MD, −7.59 mg/dL; 95% CI, −15.09 to −0.81), and insulin (MD −0.79 μIU/L; 95% CI, −1.36 to −0.21) were significantly reduced in the patients with vitamin D supplementation.

Conclusion

Our results showed significantly reduced ALT, AST, GGT, triglycerides, insulin, and HOMA-IR in the vitamin D–supplemented group; however, the effect was modest. In addition, there were no differences in survival, CAP, or LSM. Further RCTs with adequate power are warranted to clarify the results. Systematic Review Registration PROSPERO registration No. CRD42022370312

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Vitamin DDietary SupplementsVitamin D DeficiencyLiver DiseasesVitaminsHumansRandomized Controlled Trials as TopicChronic DiseaseMaleFemale

Stichwörter der Autor:innen

chronic liver diseaseliver cirrhosismicronutrientvitamin D

Substanzen

Vitamin DVitamins

Autor:innen und Institutionen

  • Centre for Translational Medicine, Semmelweis University, Budapest 1085, Hungary.
  • Institute for Clinical and Experimental Medicine, Prague 140 21, Czech Republic.
  • Carol Davila University of Medicine and Pharmacy, Bucharest 050474, Romania.
  • Institute of Pancreatic Diseases, Semmelweis University, Budapest 1083, Hungary.
  • Institute for Translational Medicine, University of Pécs, Medical School, Pécs 7623, Hungary.
  • Department of Biophysics and Radiation Biology, Semmelweis University, Budapest 1094, Hungary.

ORCID-Profile: Petrana Martinekova

Zitieren

APA

Martinekova, P., Obeidat, M., Topala, M., Váncsa, S., Veres, D. S., Zolcsák, Á., Pál, M., Földvári-Nagy, L., Banovcin, P., Erőss, B., Hegyi, P., & Hagymasi, K. (2025). Role of Vitamin D Supplementation in Chronic Liver Disease: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Nutrition Reviews, 83(11), 2043-2054. https://doi.org/10.1093/nutrit/nuaf117

Vancouver

Martinekova P, Obeidat M, Topala M, Váncsa S, Veres DS, Zolcsák Á, et al. Role of Vitamin D Supplementation in Chronic Liver Disease: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Nutrition Reviews. 2025;83(11):2043-2054. doi:10.1093/nutrit/nuaf117

BibTeX
@article{Martinekova2025,
  author = {Martinekova, Petrana and Obeidat, Mahmoud and Topala, Mihaela and Váncsa, Szilárd and Veres, Dániel Sándor and Zolcsák, Ádám and Pál, Miheller and Földvári-Nagy, László and Banovcin, Peter and Erőss, Bálint and Hegyi, Péter and Hagymasi, Krisztina},
  title = {Role of Vitamin D Supplementation in Chronic Liver Disease: A Systematic Review and Meta-Analysis of Randomized Controlled Trials},
  journal = {Nutrition Reviews},
  year = {2025},
  volume = {83},
  number = {11},
  pages = {2043--2054},
  doi = {10.1093/nutrit/nuaf117}
}
Kostenlos starten →